Skip to main content

Table 1 Major NK cell receptors in melanoma

From: The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies

Receptor

Molecular

structure

Expression

Sample type

Function

NKp 30 (NCR)

Immunoglobulin Superfamily

Resting and activated NK cells

stage IV melanoma patients

Activator [75]

NKp 46 (NCR)

Immunoglobulin Superfamily

Resting and activated NK cells

stage IV melanoma patients

Activator [75]

NKp 44(NCR)

Immunoglobulin Superfamily

Activated NK cells

1106mel melanoma cell line

Activator [82]

NKp 80 (NCR)

Immunoglobulin Superfamily

Resting and activated NK cells

melanoma metastasis patients

Activator [83]

NKG2D

C-type lectins

NK, gamma delta T, CD8+

T cells

stage III–IV melanoma patients

Activator [1]

DNAM-1(CD226)

Immunoglobulin Superfamily

All NK cells, T cells and monocytes

B16F10 melanoma cell line

Activator [84]

KIR

Immunoglobulin Superfamily

NK, T cells

stage I–IV melanoma patients/ melanoma cell line

Inhibitor/ Activator [62]

NKG2A/CD94

C-type lectins

NK, Cytotoxic T-lymphocyte

B16F10 melanoma cell line

Inhibitor [85]